Contrasting Mazor Robotics (MZOR) & Becton Dickinson and (BDX)

Mazor Robotics (NASDAQ: MZOR) and Becton Dickinson and (NYSE:BDX) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, earnings and analyst recommendations.

Dividends

How to Become a New Pot Stock Millionaire

Becton Dickinson and pays an annual dividend of $3.00 per share and has a dividend yield of 1.3%. Mazor Robotics does not pay a dividend. Becton Dickinson and pays out 31.6% of its earnings in the form of a dividend. Becton Dickinson and has raised its dividend for 46 consecutive years.

Profitability

This table compares Mazor Robotics and Becton Dickinson and’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mazor Robotics -19.08% -14.03% -11.65%
Becton Dickinson and 2.71% 16.19% 5.74%

Valuation & Earnings

This table compares Mazor Robotics and Becton Dickinson and’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mazor Robotics $64.95 million 24.22 -$12.41 million ($0.50) -123.30
Becton Dickinson and $12.09 billion 5.05 $1.10 billion $9.48 24.22

Becton Dickinson and has higher revenue and earnings than Mazor Robotics. Mazor Robotics is trading at a lower price-to-earnings ratio than Becton Dickinson and, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations and price targets for Mazor Robotics and Becton Dickinson and, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mazor Robotics 3 4 1 0 1.75
Becton Dickinson and 0 4 10 1 2.80

Mazor Robotics currently has a consensus price target of $40.00, suggesting a potential downside of 35.12%. Becton Dickinson and has a consensus price target of $240.00, suggesting a potential upside of 4.54%. Given Becton Dickinson and’s stronger consensus rating and higher possible upside, analysts clearly believe Becton Dickinson and is more favorable than Mazor Robotics.

Insider & Institutional Ownership

24.1% of Mazor Robotics shares are held by institutional investors. Comparatively, 83.5% of Becton Dickinson and shares are held by institutional investors. 1.0% of Becton Dickinson and shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk and Volatility

Mazor Robotics has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Becton Dickinson and has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500.

Summary

Becton Dickinson and beats Mazor Robotics on 15 of the 18 factors compared between the two stocks.

Mazor Robotics Company Profile

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. The company operates in the field of image guided surgery and computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness. It offers Mazor X surgical guidance system and Renaissance surgical guidance system that transform spine surgery from freehand procedures to guided procedures. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company’s BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply